These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35672283)

  • 1. Structural insights into human brain-gut peptide cholecystokinin receptors.
    Ding Y; Zhang H; Liao YY; Chen LN; Ji SY; Qin J; Mao C; Shen DD; Lin L; Wang H; Zhang Y; Li XM
    Cell Discov; 2022 Jun; 8(1):55. PubMed ID: 35672283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity.
    Mobbs JI; Belousoff MJ; Harikumar KG; Piper SJ; Xu X; Furness SGB; Venugopal H; Christopoulos A; Danev R; Wootten D; Thal DM; Miller LJ; Sexton PM
    PLoS Biol; 2021 Jun; 19(6):e3001295. PubMed ID: 34086670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional characterization of cionin receptors in the ascidian, Ciona intestinalis: the evolutionary origin of the vertebrate cholecystokinin/gastrin family.
    Sekiguchi T; Ogasawara M; Satake H
    J Endocrinol; 2012 Apr; 213(1):99-106. PubMed ID: 22289502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.
    Cawston EE; Lam PC; Harikumar KG; Dong M; Ball AM; Augustine ML; Akgün E; Portoghese PS; Orry A; Abagyan R; Sexton PM; Miller LJ
    J Biol Chem; 2012 May; 287(22):18618-35. PubMed ID: 22467877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
    Berna MJ; Tapia JA; Sancho V; Jensen RT
    Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.
    Galés C; Poirot M; Taillefer J; Maigret B; Martinez J; Moroder L; Escrieut C; Pradayrol L; Fourmy D; Silvente-Poirot S
    Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia.
    Zhou L; Yang H; Okoro EU; Guo Z
    J Biol Chem; 2014 May; 289(19):12989-99. PubMed ID: 24692543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.
    Dong M; Vattelana AM; Lam PC; Orry AJ; Abagyan R; Christopoulos A; Sexton PM; Haines DR; Miller LJ
    Mol Pharmacol; 2015 Jan; 87(1):130-40. PubMed ID: 25319540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
    J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression.
    Wan Y; Deng Q; Zhou Z; Deng Y; Zhang J; Li J; Wang Y
    Poult Sci; 2023 Jan; 102(1):102273. PubMed ID: 36436379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.
    Desai AJ; Harikumar KG; Miller LJ
    J Biol Chem; 2014 Jun; 289(26):18314-26. PubMed ID: 24825903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cholecystokinin, gastrin, and their receptors in the mouse cornea.
    Gonzalez-Coto AF; Alonso-Ron C; Alcalde I; Gallar J; Meana Á; Merayo-Lloves J; Belmonte C
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1965-75. PubMed ID: 24576871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor.
    Desai AJ; Mechin I; Nagarajan K; Valant C; Wootten D; Lam PCH; Orry A; Abagyan R; Nair A; Sexton PM; Christopoulos A; Miller LJ
    Mol Pharmacol; 2019 Mar; 95(3):245-259. PubMed ID: 30591538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol.
    Harikumar KG; Coudrat T; Desai AJ; Dong M; Dengler DG; Furness SGB; Christopoulos A; Wootten D; Sergienko EA; Sexton PM; Miller LJ
    Front Endocrinol (Lausanne); 2021; 12():789957. PubMed ID: 34950108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor.
    Liu Q; Yang D; Zhuang Y; Croll TI; Cai X; Dai A; He X; Duan J; Yin W; Ye C; Zhou F; Wu B; Zhao Q; Xu HE; Wang MW; Jiang Y
    Nat Chem Biol; 2021 Dec; 17(12):1238-1244. PubMed ID: 34556862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK1R agonists: a promising target for the pharmacological treatment of obesity.
    Szewczyk JR; Laudeman C
    Curr Top Med Chem; 2003; 3(8):837-54. PubMed ID: 12678836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands.
    Kopin AS; McBride EW; Quinn SM; Kolakowski LF; Beinborn M
    J Biol Chem; 1995 Mar; 270(10):5019-23. PubMed ID: 7890609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of the human cholecystokinin receptors bound to agonists and antagonists.
    Zhang X; He C; Wang M; Zhou Q; Yang D; Zhu Y; Feng W; Zhang H; Dai A; Chu X; Wang J; Yang Z; Jiang Y; Sensfuss U; Tan Q; Han S; Reedtz-Runge S; Xu HE; Zhao S; Wang MW; Wu B; Zhao Q
    Nat Chem Biol; 2021 Dec; 17(12):1230-1237. PubMed ID: 34556863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.